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extensively studied in vitro (primarily with DNA frag-
ments containing various prokaryotic and eukaryotic
DNA sequences) to reveal the fundamental aspects of
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The Scripps Research Institute DNA recognition, binding, and cleavage [6–9]. Addition-
ally, experiments mimicking in vivo conditions with ei-10550 North Torrey Pines Road
La Jolla, California 92037 ther isolated nuclei or nucleosome core particles have
clearly demonstrated the importance of local DNA con-
formation and flexibility as well as steric constraints
posed by sequence in the recognition and cleavage ofSummary
DNA by calicheamicin [10–12]. The effects of the drug
in vivo have not been well investigated, although theWe have investigated the mode of action of cali-
cheamicin in living cells by using oligonucleotide mi- suggestion has been made from experiments with
MOLT-4 cells (a human leukemic cell line with a 1000-croarrays to monitor its effects on gene expression
across the entire yeast genome. Transcriptional ef- fold greater susceptibility than that of other cell lines)
that cytotoxicity of enediynes might involve additionalfects were observed as early as 2 min into drug expo-
sure. Among these effects were the upregulation of protein-mediated mechanisms [13]. Here we have inves-
tigated the mode of action of calicheamicin in vivo bytwo nuclear proteins encoding a Y-helicase (a sub-
telomerically encoded protein whose function is to using oligonucleotide microarrays to profile the effects
on gene transcription in wild-type yeast.maintain telomeres) and a suppressor of rpc10 and
rpb40 mutations (both rpc10 and rpb40 encode RNA
polymerase subunits). With longer calicheamicin ex-
Results and Discussionposure, genes involved in chromatin arrangement,
DNA repair and/or oxidative damage, DNA synthesis
Saccharomyces cerevisiae was grown at 30C in liquidand cell cycle checkpoint control as well as other nu-
culture to an O.D. of 1.0 and subsequently exposed toclear proteins were all differentially expressed. Addi-
CLM (10 and 100 ng/ml, in duplicate) for 2 min, 15 min,tionally, ribosomal proteins and a variety of metabolic,
and 30 min, respectively. The medium was then re-biosynthetic, and stress response genes were also
moved, the cells were washed thoroughly (3) with dis-altered in their expression.
tilled water, and total RNA was isolated by hot phenol
extraction. Although the external supply of calicheami-Introduction
cin is greatly diminished upon removal of the medium,
intracellular calicheamicin can still induce cleavage andCalicheamicin 1I (CLM) is one of the enediyne family of
invoke transcriptional changes until the RNA is finallysecondary metabolites, a class of naturally occurring
extracted with hot phenol. Biotinylated cRNA was thenanti-tumor antibiotics that include neocarzinostatin,
prepared, fragmented, and subsequently hybridized (twoesperamicin, dynemicin, and kedarcidin. Results of in
independent hybridizations) to yeast (Ye6100) oligonucle-vitro experiments suggest that members of this family
otide arrays. On a global level, across the approximatelyelicit their lethal effects by promoting DNA strand scis-
6200 genes that constitute the entire yeast genome, wesion through radical mechanisms. However, they differ
detected consistent expression-level changes of 2-foldboth in their sequence selectivity and in their ability to
in approximately 60 genes between cells treated with cali-invoke either single- or double-strand breaks. Cali-
cheamicin at the high dose and longest time point (100cheamicin is one of the most sequence selective of this
ng/ml, 30 min.; Table 1) versus untreated cells. A sub-class and has a strong preference reported (in naked
stantial fraction of these genes (approximately 35%) wereDNA) for TCCT and poly-A/T sequences [1–4]. Activation
nuclear-related responses including genes involved inof the drug and DNA cleavage is proposed to result from
chromatin arrangement, DNA repair and/or oxidativenucleophilic attack on the allylic methyltrisulfide of CLM
damage, DNA synthesis, and cell cycle control. The re-by a reductant (presumed to be the thiolate anion of
mainder included ribosomal proteins and genes in-glutathione in vivo), promoting intramolecular addition
volved in stress response, biosynthesis, and metab-of thiolate to the dienone with subsequent electrocyliza-
olism.tion to give the highly reactive 1,4-didehydrobenzene.
Histones were among the genes whose expressionSingle- and double-stranded cuts are thought to arise
changed the most upon calicheamicin treatment. Con-when this diradical, positioned within the minor groove
current downregulation of histones H2A (approximatelyof DNA, abstracts hydrogen atoms from the deoxyribose
5-fold; average), H2B (approximately 4-fold; average),backbone [5]. The resulting DNA radicals scavenge oxy-
H3 (3–4 fold) and H4 (approximately 3-fold; average) wasgen and initiate a sequence of events that ultimately
observed. Histones regulate germination as well as theleads to strand scission.
response to heat shock and nutrient starvation [14]. BothThe interaction of calicheamicin with DNA has been
H2A/H2B and H3/H4 mutants have been shown to form
reduced-size colonies on plates and to exhibit a 30%1Correspondence: schultz@scripps.edu
2 These authors contributed equally to this work. increase in doubling time in liquid medium [15]. They
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Table 1. Effect of Calicheamicin on Yeast at 2 min, 15 min, and 30 min of Incubation with 10 ng/ml and 100 ng/ml of Drug
Fold Changea,b
Probe Set Gene/Description (at 2 min) (at 15 min) (at 30 min)
Ribosomal Proteins
YMR230W/_ex1_at Ribosomal protein S10 (rat S10), nearly identical to -- 2 --
Rps10Ap – – –
YDL075W/RPL43A_ex1 Ribosomal protein L31 (yeast L34; YL36; YL28; rat L31), -- -- --
nearly identical to Rpl31Bp – 3.6 –
YKL180W/RPL17_ex2 Ribosomal protein L17 (yeast L20; YL17; E. coli L22; rat -- -- --
and human L17), nearly identical to Rpl17Bp – – 2
YKR057W/RPS25_ex Ribosomal protein S21 (yeast S26; YS25; rat S21), identi- -- -- --
cal to Rps21Bp – – 2.2
YMR230W/_ex2_f_at Ribosomal protein S10 (rat S10), nearly identical to -- -- --
Rps10Ap – – 2.7
YLR197W/SIK1_at Nucleolar protein component of box C/D snoRNPs, -- -- --
which are necessary for 2-O-methylation of ribosomal – – 2
RNAs
YMR131C/_at Protein involved in ribosome assembly, member of WD -- -- --
(WD-40) repeat family – – 3.5
RNA Polymerases
YER148wM_at TATA-binding component of RNA polymerases I, II, and -- -- --
III; part of initiation factors TFIID and TFIIIB – – 2
YJL148W/_at RNA polymerase I subunit, not shared with other RNA -- -- --
polymerases – – 3
YJR063W/RPA12_at RNA polymerase I subunit A 12.2 -- -- --
– – 4.5
Chromatin Arrangement
YBL003c/HTA2_at Histone H2A -- -- 2.3
– 3.1 8.1
YDR225w/HTA1_f_at Histone H2A -- -- --
– – 3.4
YDR225w/HTA1_i_at Histone H2A -- -- --
– – 3.3
YDR224c/HTB1_at Histone H2B -- -- --
– – 2.7
YBL002w/HTB2_at Histone H2B -- -- 2.7
– 4.1 10.6
YBR010w/HHT1_at Histone H3 -- -- 2
– 3.2 3.8
YBR009c/HHF1_f_at Histone H4 -- -- 2.2
– 2.7 3.6
YNL030W/HHF2_f_at Histone H4 -- -- --
– – 3.3
YOL012C/_at Histone-related protein that can suppress histone H4 -- -- --
point mutation – – 2
DNA Repair/Oxidative Damange
YDL101C/DUN1_at Protein kinase required for induction for Rnr3p and DNA -- -- --
repair genes after DNA damage – 2.8 3.2
DNA Synthesis
YER070w/RNR1_at Ribonucleotide reductase large subunit -- -- --
– 6.4 7.9
YJL026W/RNR2_at Component of ribonucleotide reductase small subunit -- -- 2.5
– 2.6 3.6
YIL066C/RNR3_at Ribonucleotide reductase large regulatory subunit -- 2.4 3.7
– 5.3 7.6
YGR180C/RNR4_at Component of ribonucleotide reductase small subunit -- -- --
– 2.5 2.2
YNL141W/_at Adenine deaminase (adenine aminohydrolase), enzyme -- -- --
of the purine salvage pathway; has similarity to – 2.2 2.7
adenosine deaminases
YBL039C/_at CTP synthase; final step in pyrimidine biosynthesis -- -- --
pathway – 2.3 –
YGL037C/_at Pyrazinamidase and nicotinamidase -- -- --
– 2 2.3
(continued)
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Table 1. Continued.
Fold Changea,b
Probe Set Gene/Description (at 2 min) (at 15 min) (at 30 min)
Nuclear
YBL113C/_i_at Unknown function, subtelomerically encoded 6 -- --
5 – –
YBL113/_r_i_at Unknown function, subtelomerically encoded 6.9 -- --
4 – –
YKR092C/SRP40_at Suppressor of rpc40 and rpb10 mutations 2.1 -- --
4.2 – –
YIL177C/_ex2_f_at Protein with similarity to subtelomerically-encoded -- -- 2.1
proteins – – 2.4
YBR214w/_at Nuclear protein with similarity to S. pombe sds23.moe1 -- -- 2
protein – – 3.4
YOR185C/GSP2_at Ran, a GTP-binding protein member of the ras super- -- -- --
family involved in trafficking through nuclear pores – – 2.8
YER002w/_at Nuclear protein of unknown function -- -- --
– – 2.1
YOR051C/_at Nuclear protein of unknown function -- -- 2.1
– – 2.2
Cell Cycle
YDL179W/_at Cyclin that associates with Pho85p -- -- --
– 4.1 –
YAR007C/RFA1_at DNA replication factorA, 69K subunit, binds single- -- -- --
stranded DNA – – 2.1
YNL312W/RFA2_ex1_at DNA replication factorA, 36 subunit; phosphorylated at -- -- --
the G1/S transition and dephosphorylated at mitosis – – 2.2
YPL256C/CLN2_at G1/S-specific cylin, interacts with Cdc28 protein kinase -- -- --
to control events at START – 2.8 –
YIL065C/_at Protein involved in mitochondrial division -- -- 2.8
– 3 3.4
YNL327W/_at Cell-cycle regulation protein, may be involved in the -- -- --
correct timing of cell separation after cytokinesis – – 3.5
YOR272W/_at Microtubule-associated protein essential for the G1/S -- -- --
transition, member of WD (WD-40) repeat family – 3.6 –
YGL134W/_at Cyclin that associates with Pho85p, involved in glycogen -- -- 2
accumulation – – –
a Italic  10 ng/ml of calicheamicin (--).
b Bold  100 ng/ml of caliceamicin (–).
also fail to undergo meiotic division and sporulate, indi- Cdc28 protein kinase to control START-specific pro-
cesses [22–24]. The cells used in this experiment werecating a cell cycle delay in late S, G2, or M phase [14].
Histones were among the earliest to respond to cali- not synchronized, and the changes in the expression
level of these genes may reflect various cell cycle delayscheamicin treatment, and delay in the cell cycle may be
the first of a cascade of events in the response of yeast invoked in DNA-damaged cells. We tested the effects of
calicheamicin on synchronized cells but did not observecells to insult by DNA damage (Figure 1). In keeping with
this methylmethane sulfonate (MMS), a DNA-alkylating any significant shift in the population of cells to any one
stage of the cell cycle (data not shown).agent has also been shown to decrease the expression
of histones [16]. Consistent with the DNA-cleaving properties attrib-
uted to calicheamicin in vitro, we observed upregulationUpon calicheamicin exposure, various cell cycle
genes, including two cyclins, PCl9 (YDL179W) and of genes involved in DNA repair and protection against
oxidative damage, as well as genes involved in DNAPCl10(YGL134W), respectively, were repressed. Both of
these cylcins were found to associate with Pho85 (a synthesis. DNA repair pathways include base and nucle-
otide excision repair as well as recombinational repairregulator of cell cycle progression) [17–18]. PCl9 has
been shown to form a functional cyclin-Cdk complex [25]. Calicheamicin treatment appears to activate both
pathways to varying degrees, consistent with the single-that phosphorylates Pho4p, and it is the only cyclin
known to act in the late M phase/early G1 [19–20]. Fur- and double-strand cleaving properties associated with
this drug. For example, both RFA1 and RFA2, DNA repli-thermore, EGT2 (YNL327W), which has been shown to
be transcriptionally coregulated in the cell cycle with cation factors that belong to the RF-A complex (Rfa1p-
Rfa2p-Rfa3p), were upregulated. The complex acts earlyPCL9, was also repressed in its expression [21]. Other
genes that were downregulated in their expression in- in nucleotide excision repair in DNA damage recognition
and acts to regulate the expression of DNA repair andcluded YTM1 (YOR272W), a microtubule-associated
protein essential for the G1/S transition, and CLN2 DNA metabolism genes [26]. The RFA heterotrimeric
complex is also involved in recombination and has been(YPL256C), a G1/S-specific cyclin that interacts with
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Figure 1. Effect of Calicheamicin and Methylmethanesulfonate on Yeast Growth as Measured by O.D.600
shown to stimulate DNA strand exchange [27]. mRNA whereas AAH1 is an adenine deaminase (adenine amino-
hydrolase), an enzyme of the purine salvage path-expression levels of these proteins peak at the G1/S
phase boundary. They are also increased by methyl- way, and converts adenosine to inosine [33–36]. Both
of these genes have also been shown to be repressedmethanesulfonate treatment [16].
DUN1, a protein also involved in the DNA damage in their expression by treatment with methylmethanesul-
fonate [16].sensory pathway, was shown to be upregulated by 2–3
fold with calicheamicin treatment. DUN1 is a protein Nuclear proteins, with less defined roles, were also
affected at the transcriptional level. For example, SDS24kinase that is required for the induction of ribonucleotide
reductase genes and DNA repair genes after DNA dam- (YBR214W), a protein 62% identical to the spindle pole
body protein SDS23, was upregulated by 2-fold in itsage [28]. Phosphorylation has been shown to increase
in response to DNA damage in a Dun1p-dependent man- expression. sds23/moc1 is a multicopy suppressor of
protein phosphatase 1 mutants. High osmolarity as wellner [29]. mRNA abundance of the protein has been
shown to peak in late G1 phase [30]. MMS treatment has as cell-damaging conditions have been shown to induce
mRNA levels of this protein [37]. Moreover, overproduc-also been shown to increase phosphorylation activity
by 6-fold [31]. Likewise, all four of the ribonucleotide tion of this protein in E. coli has been shown to elicit an
SOS response [38]. Both YOR051C and YER002W werereductase subunits that compose the 2-	2 tetramer
required for DNA synthesis were shown to be upregu- downregulated in their expression by 2-fold and have
been shown to purify with proteins associated with thelated upon treatment with calicheamicin. The tetramer
consists of two large (Rnr1p and Rnr3p) and two small nuclear pore complex [39]. Homozygous diploid mu-
tants of these proteins have each been shown to exhibit(Rnr2p and Rnr4p) subunits and is induced by double-
strand DNA breaks generated directly by DNA-damag- a reduced growth rate [40].
Other genes that altered in expression on a globaling agents or indirectly by DNA repair processes [32].
Other genes related to DNA synthesis and nucleotide level included a variety of ribosomal proteins, heat shock
proteins, multidrug resistance proteins, biosyntheticmetabolism were also differentially expressed; for ex-
ample, URA7 and AAH1 were downregulated. URA7 is and metabolic proteins, cell wall proteins, and proteins
of unknown function. Although, a complete descriptiona CTP synthase that catalyzes the formation of dCTP
from dUTP, the final step in pyrimidine biosynthesis, of these genes and their functions is beyond the scope
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of this article, a complete list of the genes with their fold calicheamicin-induced DNA damage. Employing a
range of concentrations, we treated yeast cultures (0.1changes can be found at the following website: ftp://
schultzftp.scripps.edu/pub/Coran/CLM_Table_1.xls. O.D.) with the drug and monitored them by UV in a time
course analysis (Figures 1A and 1B). Drug treatmentsWhether calicheamicin can target DNA or DNA/protein
complexes selectively within a cell and favor cleavage were repeated in triplicate, and standard curves were
generated to normalize against differences in growthof particular chromosomal sites is unknown. Cali-
cheamicin, as well as other enediynes of its class, have rate.
Overexpression of YBL113C, the Y-helicase, wasbeen shown to recognize local DNA conformation and
deformability and are thought to bind through an in- shown to be protective against the DNA-damaging ef-
fects of calicheamicin, whereas deletion of SRP40,duced-fit mechanism [9]. Interestingly, at 2 min of cali-
cheamicin exposure (10 ng/ml, the lowest dose), we YKR092C, had a slight detrimental effect. (It should be
noted that the IC50 of calicheamicin on yeast cell growthobserved differential expression of only six genes that
changed 2-fold. Two nuclear genes (YBL113C and is approximately 500 ng/ml [in culture]). For comparison,
we also tested the effects of another DNA damageYKR092C) were among these, as well as four other
genes that are most likely related to stress response. agent, methylmethanesulfonate (MMS; DDW as a con-
trol), on both yeast strains. The results are depicted inThese four included two heat shock proteins (YCR021C
and YBR005W) and two proteins involved in cell wall the right panels of Figures 1A and 1B. In both instances
the effects of MMS on both yeast strains were minimal.biosynthesis (YBR078W and YLL025W). YCR021C, or
heat shock protein 30 (Hsp30), is a protein located in These results may reflect differences in the DNA damage
response of the cell or could potentially suggest selec-the plasma membrane and is involved in adaptation to
growth under stress conditions [41–42]. YBR005W is a tivity of calicheamicin-induced DNA cleavage.
protein that exhibits similarity to HSP30 [43]. YBR078W
is involved in cell wall maintenance and has been shown Significance
to be one of 127 genes coregulated under 26 cell-dam-
aging conditions, some of which encode proteins involved Calicheamicin 1I isolated from fermentations of Mi-
cromonospora echinospora ssp. is among a family ofin sterol metabolism, ion homeostasis, or cell wall, cy-
toskeleton, or chromatin structure [43–44]. YLL025W, en- unusually potent antitumor agents. In vitro, the drug
has been shown to interact with double-helical DNAcoding a protein of the seripauperin (PAU) family of pos-
sible cell wall mannoproteins, contains two putative in the minor groove, where it causes both single- and
double-strand breaks. The cleavage chemistry is de-stress response elements (STRE) present in the pro-
moter [45–47]. Functional genomic studies have shown pendent upon reducing agents and oxygen for activat-
ing rearrangement of the enediyne warhead to givethat the gene is coregulated among 163 other genes
under 26 different cell-damaging conditions [43]. the highly reactive 1,4-diylradical species. In vivo, acti-
vation of the drug presumably occurs by addition ofYBL113C, a subtelomerically encoded protein, was
upregulated by 4- to 7-fold and corresponds to a puta- glutathione to the methyltrisulfide. Transcriptional ef-
fects to the drug corroborate the in vitro results andtive Y-helicase (the protein is 84% identical to the Y-
helicase YJL225C) [48]. The protein has been shown clearly define the role of the drug as a DNA-damaging
agent. On a global scale, genes involved in DNA repairto amplify Y elements, highly polymorphic repetitive
sequences that are present in the subtelomeric regions and synthesis, chromatin rearrangement, cell cycle
checkpoint control, nuclear proteins, ribosomal pro-of many yeast telomeres; such sequences are found to
be induced in survivors defective for telomerase [49]. teins, metabolic and biosynthetic genes, and proteins
involved in stress response are all altered at the tran-Amplification of Y elements has also been shown to be
RAD52 dependent, a gene essential for homologous scriptional level. The transcriptional effects of cali-
cheamicin at low concentrations of drug and shortrecombination in yeast. On the other hand, YKR092C,
or SRP40, which is upregulated by 2- to 4-fold upon 2 exposure times revealed six genes that were affected
2-fold. Four of these six are probably involved inmin of calicheamicin treatment, is a protein shown to
protect against mutations induced in rpb10 and rpc40. stress response, and two are nuclear proteins, including
a Y-helicase involved in telomere maintenance and arpb10 encodes a small polypeptide (referred to as
ABC10	) that is shared among the three yeast RNA suppressor of rpc10 and rpb40 mutations (two RNA poly-
polymerases, whereas rpc40 encodes the -like subunit merase subunits). Overexpression of the Y-helicase
(AC40) of polI and polIII [50]. Interestingly, RNA polymer- was shown to be protective against calicheamicin-
ase genes were actually among those downregulated induced DNA damage but not against methylmethane-
at 15 min of calicheamicin exposure. However, SRP40 is sulfonate treatment over a range of concentrations
thought to act specifically on rpb10 and rpc40 mutants. and time points. These results may reflect either differ-
To investigate whether upregulation of these nuclear ences in the cells’ response to various DNA-damaging
proteins might make yeast less sensitive to caliche- agents or the possibility that calicheamicin may favor
amicin, we treated overexpression or deletion mutant cleavage of certain chromosomal sites.
strains of yeast with calicheamicin and compared them
Experimental Proceduresto the wild-type strain. To examine the effects of
YBL113C, we overexpressed the protein since it is sub-
Organisms and Culture Techniquestelomeric (next to telomeres) and the unavailability of a
The yeast S. cerevisiae wild-type strain YPH500 (MAT ura3-52
deletion mutant strain suggested possible lethality. A lys2-801 ade2-101 trp1-
63 his3-
200 leu2-
1) was used in this
deletion mutant strain of YKR092C was available, so investigation. For preparation of RNA samples for GeneChip hybrid-
ization, yeast samples were inoculated into 500 ml YPD mediumwe chose to use this strain to examine its effects on
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(per liter: yeast extract, 10 g; peptone, 20 g; and dextrose [20%, mutant strain. We are thankful to the Howard Hughes Life Sciences
Foundation for a postdoctoral fellowship for C.M.H.W and to Dr.10 solution, autoclaved separately], 100 ml) and grown to an O.D.600
of 1 at 30C, 250 rpm. Cultures were then split into 30 ml aliquots, Craig A. Townsend (The Johns Hopkins University) for his helpful
discussions.and for each time point calicheamicin 1I (dissolved in ethanol) was
added to one culture while another received ethanol alone. For time
course experiments, both YKR092C and BY4743 were grown in
Received: August 13, 2001standard YPD medium. However, YBL113C was grown in URA
Revised: November 8, 2001minimal medium, and YPH500was grown in minimal medium. Mini-
Accepted: November 13, 2001mal medium contains (per 100 ml) 10 ml nitrogen base (6.7%) 3 ml
histidine (1 mg/ml), 3 ml trptophan (1 mg/ml), 3 ml leucine (1 mg/ml),
2 ml adenine (1 mg/ml), 2 ml uracil (1 mg/ml), glucose (20%), and References
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